SZ441 (Metformin Hydrochloride and Pioglitazone Hydrochloride 500 mg / 15 mg (base))
Pill with imprint SZ441 is White, Elliptical/Oval and has been identified as Metformin Hydrochloride and Pioglitazone Hydrochloride 500 mg / 15 mg (base). It is supplied by Sandoz Inc.
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 500 mg / 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ441
Metformin Hydrochloride and Pioglitazone Hydrochloride
- Imprint
- SZ441
- Strength
- 500 mg / 15 mg (base)
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5626
- Inactive Ingredients
-
croscarmellose sodium,
hypromellose 2910 (6 mPa.s),
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 6000,
povidone k25,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about metformin / pioglitazone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
Patient resources
- Drug Information
- Pioglitazone and metformin (Advanced Reading)
- Pioglitazone and Metformin Extended-Release Tablets
- Pioglitazone and Metformin Tablets
- Other brands
- ActoPlus Met, ActoPlus Met XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.